Award
NIH Reporter #1U19AI171443-01
Center for Antiviral Medicines & Pandemic Preparedness (CAMPP)
Recipient
SCRIPPS RESEARCH INSTITUTE, THE
Award Amount
$67,624,156.00
Ceiling
$67,624,156.00
Awarded
May 16, 2022
Identifier
1U19AI171443-01
CAMPP is a multidisciplinary project funded by NIAID to develop antiviral therapeutics targeting SARS-CoV-2 and other RNA viruses with pandemic potential, focusing on oral inhibitors and advancing drug candidates through preclinical stages.
Description
The project aims to develop antiviral therapeutics against SARS-CoV-2 and other RNA viruses of pandemic potential, including flaviviruses and hemorrhagic fever viruses. It involves multidisciplinary approaches in drug discovery, virology, chemistry, structural biology, and partnerships with biopharmaceutical companies. The focus is on developing oral bioavailable inhibitors for viral proteases, RNA polymerases, helicases, ion channels, and structural proteins, with the goal of obtaining in vivo proof-of-concept and advancing promising assets into IND-enabling studies.